Using endophenotypes for pathway clusters to map complex disease genes

Genetic Epidemiology

Volumn 30, Issue 2, 2006, Pages 143-154

  Pan, Wen Harn ^a   Lynn, Ke Shiuan ^a   Chen, Chun Houh ^b   Wu, Yi Lin ^a   Lin, Chung Yen ^c,d   Chang, Hsing Yi ^c  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d INSTITUTE OF INFORMATION SCIENCE   (Taiwan)

Author keywords

Data mining; Dimension reduction; Endophenotype; Intermediate phenotype; Microarray; Pathway cluster

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; ENDOPHENOTYPE; GENE CLUSTER; GENE EXPRESSION; GENE IDENTIFICATION; GENE MAPPING; GENETIC ANALYSIS; GENETIC TRAIT; GENOTYPE; PHENOTYPE; PROTEIN EXPRESSION; REPRODUCIBILITY; STATISTICAL ANALYSIS;

CHROMOSOME MAPPING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; MALE; MODELS, GENETIC; MODELS, STATISTICAL; PHENOTYPE; QUANTITATIVE TRAIT LOCI;

EID: 32044450082     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/gepi.20136     Document Type: Article

References (75)

1. Anonymous. 1999. Proteomics, transcriptomics: what's in a name? Nature 402:715.
2. Agarwal A, Williams GH, Fisher ND. 2005. Genetics of human hypertension. Trends Endocrinol Metab 16:127-133.
3. Aron AR, Poldrack RA. 2005. The cognitive neuroscience of response inhibition: relevance for genetic research in attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1285-1292.
4. Barczak A, Rodriguez MW, Hanspers K, Koth LL, Tai YC, Bolstad BM, Speed TP, Erie DJ. 2003. Spotted long oligonucleotide arrays for human gene expression analysis. Genome Res 13:1775-1785.
5. Bolshakova N, Azuaje F, Cunningham P. 2005. An integrated tool for microarray data clustering and cluster validity assessment. Bioinformatics 21:451-455.
6. Chiano MN, Yates JR. 1995. Linkage detection under heterogeneity and the mixture problem. Ann Hum Genet 59:83-95.
7. Chon H, Gaillard CA, van der Meijden BB, Dijstelbloem HM, Kraaijenhagen RJ, van Leenen D, Holstege FC, Joles JA, Bluyssen HA, Koomans HA, et al. 2004. Broadly altered gene expression in blood leukocytes in essential hypertension is absent during treatment. Hypertension 43:947-951.
8. Cook NR, Zee RY, Ridker PM. 2004. Tree and spline based association analysis of gene-gene interaction models for ischemic stroke. Stat Med 23:1439-1453.
9. Cornblatt BA, Malhotra AK. 2001. Impaired attention as an endophenotype for molecular genetic studies of schizophrenia. Am J Med Genet 105:11-15.
10. de Geus EJ. 2002. Introducing genetic psychophysiology. Biol Psychol 61:1-10.
11. Falk CT. 2003. Risk factors for coronary artery disease and the use of neural networks to predict the presence or absence of high blood pressure. BMC Genet 4 Suppl 1:S67.
12. Fan H, Hegde PS. 2005. The transcriptome in blood: challenges and solutions for robust expression profiling. Curr Mol Med 5:3-10.
13. Fayyad UM, Piaetsky-Shapiro G, Smyth P. 1996. From data mining to knowledge discovery: an overview. In: Advances in knowledge discovery and data mining. Cambridge MA: AAAI/MIT Press.
14. Feezor RJ, Baker HV, Mindrinos M, Hayden D, Tannahill CL, Brownstein BH, Fay A, MacMillan S, Laramie J, Xiao W, Moldawer LL, Cobb JP, Laudanski K, Miller-Graziano CL, Maier RV, Schoenfeld D, Davis RW, Tompkins RG, Inflammation and Host Response to Injury-Large-Scale Collaborative Research Program. 2004. Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol Genomics 19:247-254.
15. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. 1991. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416-422.
16. Fischer M, Broeckel U, Holmer S, Baessler A, Hengstenberg C, Mayer B, Erdmann J, Klein G, Riegger G, Jacob HJ, Schunkert H. 2005. Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Circulation 111:855-862.
17. Gladkevich A, Kauffman HF, Korf J. 2004. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 28:559-576.
18. Glazier AM, Nadeau JH, Aitman TJ. 2002. Finding genes that underlie complex traits. Science 298:2345-2349.
19. Goldin LR, Gershon ES. 1988. Power of the affected-sib-pair method for heterogeneous disorders. Genet Epidemiol 5:35-42.
20. Gottesman II, Gould TD. 2003. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160:636-645.
21. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. 2004. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433-438.
22. Hack CJ. 2004. Integrated transcriptiome and proteome data: the challenges ahead. Brief Funct Genom Proteom 3:212-219.
23. Hakonarson H, Halapi E. 2002. Genetic analyses in asthma: current concepts and future directions. Am J Pharmacogenom 2:155-166.
24. Huang J, Lin A, Narasimhan B, Quertermous T, Hsiung CA, Ho LT, Grove JS, Olivier M, Ranade K, Risch NJ, Olshen RA. 2004. Tree-structured supervised learning and the genetics of hypertension. Proc Natl Acad Sci USA 101:10529-10534.
25. Huntington's Disease Collaborative Research Group. 1993. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72:971-983.
26. Ip WF, Dupuis A, Ellis L, Beharry S, Morrison J, Stormon MO, Corey M, Rommens JM, Durie PR. 2002. Serum pancreatic enzymes define the pancreatic phenotype in patients with Shwachman-Diamond syndrome. J Pediatr 141:259-265.
27. Kammerer CM, Gouin N, Samollow PB, VandeBerg JF, Hixson JE, Cole SA, MacCluer JW, Atwood LD. 2004. Two quantitative trait loci affect ACE activities in Mexican-Americans. Hypertension 43:466-470.
28. Kaplan NM, Lieberman E, Neal W. 2002. Kaplan's clinical hypertension: Lippincott Williams & Wilkins.
29. Kaufman L, Rousseeuw P. 1990. Finding groups in data: an introduction to cluster analysis. New York: Wiley.
30. Kerr MK, Martin M, Churchill GA. 2000. Analysis of variance for gene expression microarray data. J Comput Biol 7:819-837.
31. Khoury MJ, Beaty TH, Cohen BH. 1993. Fundamentals of genetic epidemiology. New York: Oxford University Press.
32. Krallinger M, Erhardt RA, Valencia A. 2005. Text-mining approaches in molecular biology and biomedicine. Drug Discov Today 10:439-445.
33. Lenzenweger MF. 1999. Schizophrenia: refining the phenotype, resolving endophenotypes. Behav Res Ther 37:281-295.
34. Li KC. 2002. Genome-wide coexpression dynamics: theory and application. Proc Natl Acad Sci USA 99:16875-16880.
35. Listgarten J, Damaraju S, Poulin B, Cook L, Dufour J, Driga A, Mackey J, Wishart D, Greiner R, Zanke B. 2004. Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms. Clin Cancer Res 10:2725-2737.
36. Liu B, Cui Q, Jiang T, Ma S. 2004. A combinational feature selection and ensemble neural network method for classification of gene expression data. BMC Bioinform 5:136.
37. Mathis CA, Klunk WE, Price JC, DeKosky ST. 2005. Imaging technology for neurodegenerative diseases: progress toward detection of specific pathologies. Arch Neurol 62:196-200.
38. Matsunaga H, Hangai N, Aso Y, Okano K, Kawamura M, Kobayashi K, Kambara H, Hoger JH, Mitsuhashi M. 2002. Application of differential display to identify genes for lung cancer detection in peripheral blood. Int J Cancer 100:592-599.
39. Menten B, Pattyn F, De Preter K, Robbrecht P, Michels E, Buysse K, Mortier G, De Paepe A, van Vooren S, Vermeesch J, Moreau Y, De Moor B, Vermeulen S, Speleman F, Vandesompele J. 2005. arrayCGHbase: an analysis platform for comparative genomic hybridization microarrays. BMC Bioinformatics 6:124.
40. Moore RC, Xiang F, Monaghan J, Han D, Zhang Z, Edstrom L, Anvret M, Prusiner SB. 2001. Huntington disease phenocopy is a familial prion disease. Am J Hum Genet 69:1385-1388.
41. Moskau S, Golla A, Grothe C, Boes M, Pohl C, Klockgether T. 2005. Heritability of carotid artery atherosclerotic lesions: an ultrasound study in 154 families. Stroke 36:5-8.
42. Oliver SG, Winson MK, Kell DB, Baganz F. 1998. Systematic functional analysis of the yeast genome. Trends Biotechnol 16:373-378.
43. Ollier W, Sprosen T, Peakman T. 2005. UK Biobank: from concept to reality. Pharmacogenomics 6:639-646.
44. Pan WH, Chen JW, Fann C, Jou YS, Wu SY. 2000. Linkage analysis with candidate genes: the Taiwan young-onset hypertension genetic study. Hum Genet 107:210-215.
45. Park PJ, Cao YA, Lee SY, Kim JW, Chang MS, Hart R, Choi S. 2004. Current issues for DNA microarrays: platform comparison, double linear amplification, and universal RNA reference. J Biotechnol 112:225-245.
46. Perusse L, Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, Walts B, Snyder EE, Bouchard C. 2005. The human obesity gene map: the 2004 update. Obes Res 13:381-490.
47. Peyser PA, Bielak LF, Chu JS, Turner ST, Ellsworth DL, Boerwinkle E, Sheedy PF 2nd. 2002. Heritability of coronary artery calcium quantity measured by electron beam computed tomography in asymptomatic adults. Circulation 106:304-308.
48. Quackenbush J. 2002. Microarray data normalization and transformation. Nat Genet 32(Suppl):496-501.
49. Quintana FJ, Hagedorn PH, Elizur G, Merbl Y, Domany E, Cohen IR. 2004. Functional immunomics: microarray analysis of autoantibody repertoires predicts the future response of mice to induced diabetes. Proc Natl Acad Sci USA 101(Suppl 2):14615-14621.
50. Reaven GM. 1988. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607.
51. Rothman KJ. 1976. Causes. Am J Epidemiol 104:587-592.
52. Saal LH, Troein C, Vallon-Christersson J, Gruvberger S, Borg A, Peterson C. 2002. BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome Biol 3:SOFTWARE003.1-003.6.
53. Segal E, Friedman N, Kaminski N, Regev A, Koller D. 2005. From signatures to models: understanding cancer using microarrays. Nat Genet 37(Suppl):S38-S45.
54. Shippy R, Sendera TJ, Lockner R, Palaniappan C, Kaysser-Kranich T, Watts G, Alsobrook J. 2004. Performance evaluation of commercial short-oligonucleotide microarrays and the impact of noise in making cross-platform correlations. BMC Genomics 5:61.
55. Shyamsundar R, Kim YH, Higgins JP, Montgomery K, Jorden M, Sethuraman A, van de Rijn M, Botstein D, Brown PO, Pollack JR. 2005. A DNA microarray survey of gene expression in normal human tissues. Genome Biol 6:R22.
56. Sillanpaa MJ, Auranen K. 2004. Replication in genetic studies of complex traits. Ann Hum Genet 68:646-657.
57. Slager SL, Huang J, Vieland VJ. 2000. Effect of allelic heterogeneity on the power of the transmission disequilibrium test. Genet Epidemiol 18:143-156.
58. Snyder EE, Walts B, Perusse L, Chagnon YC, Weisnagel SJ, Rankinen T, Bouchard C. 2004. The human obesity gene map: the 2003 update. Obes Res 12:369-439.
59. Stride A, Hattersley AT. 2002. Different genes, different diabetes: lessons from maturity-onset diabetes of the young. Ann Med 34:207-216.
60. Tanzi RE, Kovacs DM, Kim TW, Moir RD, Guenette SY, Wasco W. 1996. The gene defects responsible for familial Alzheimer's disease. Neurobiol Dis 3:159-168.
61. Taylor MA, Vaidya NA. 2005. Psychopathology in neuropsychiatry: DSM and beyond. J Neuropsychiatry Clin Neurosci 17:246-249.
62. Tomita Y, Tomida S, Hasegawa Y, Suzuki Y, Shirakawa T, Kobayashi T, Honda H. 2004. Artificial neural network approach for selection of susceptible single nucleotide polymorphisms and construction of prediction model on childhood allergic asthma. BMC Bioinformatics 5:120.
63. Trillenberg P, Lencer R, Heide W. 2004. Eye movements and psychiatric disease. Curr Opin Neurol 17:43-47.
64. Varma S, Simon R. 2004. Iterative class discovery and feature selection using Minimal Spanning Trees. BMC Bioinform 5:126.
65. Wajchenberg BL. 2000. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21:697-738.
66. Wang RY, Chung CM, Fann CSJ, Chen JW, Liu YC, Jong YS, Lo HM, Ho FM, Kang CS, Chen CC, Chang HC, Pan WH. 2005. From genomewide scan to QTL fine mapping for ACE activity with young-onset hypertension patients. The 55th Annual Meeting of The American Society of Human Genetics. Salt Lake City, Utah.
67. Weinberger MH. 1996. Salt sensitivity of blood pressure in humans. Hypertension 27:481-490.
68. Weiss LA, Veenstra-Vanderweele J, Newman DL, Kim SJ, Dytch H, McPeek MS, Cheng S, Ober C, Cook EH Jr, Abney M. 2004. Genome-wide association study identifies ITGB3 as a QTL for whole blood serotonin. Eur J Hum Genet 12:949-954.
69. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, Brown PO. 2003. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci USA 100:1896-1901.
70. Wright AF, Carothers AD, Campbell H. 2002. Gene-environment interactions-the BioBank UK Study. Pharmacogenetics J2(2):75-82.
71. Yang Q, Lai CQ, Parnell L, Cupples LA, Adiconis X, Zhu Y, Wilson PW, Housman DE, Shearman AM, D'Agostino RB, Ordovas JM. 2005. Genome-wide linkage analyses and candidate gene fine mapping for HDL3 cholesterol: the Framingham Study. J Lipid Res 46:1416-1425.
72. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP. 2002. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30:e15.
73. Yue L, Reisdorf WC. 2005. Pathway and ontology analysis: emerging approaches connecting transcriptome data and clinical endpoints. Curr Mol Med 5:11-21.
74. Zhang D, Wells MT, Smart CD, Fry WE. 2005. Bayesian normalization and identification for differential gene expression data. J Comput Biol 12:391-406.
75. Zhang SD, Gant TW. 2004. A statistical framework for the design of microarray experiments and effective detection of differential gene expression. Bioinformatics 20:2821-2828.